Suppr超能文献

人类外周血临床样本中 T 细胞受体多样性的定量分析。

Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

机构信息

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1203, United States.

出版信息

J Immunol Methods. 2012 Jan 31;375(1-2):84-92. doi: 10.1016/j.jim.2011.09.012. Epub 2011 Oct 1.

Abstract

The analysis of T cell receptor diversity provides a clinically relevant and sensitive marker of repertoire loss, gain, or skewing. Spectratyping is a broadly utilized technique to measure global TCR diversity by the analysis of the lengths of CDR3 fragments in each Vβ family. However the common use of large numbers of T cells to obtain a global view of TCR Vβ CDR3 diversity has restricted spectratyping analyses when limited T-cell numbers are available in clinical setting, such as following transplant regimens. We here demonstrate that one hundred thousand T cells are sufficient to obtain a robust, highly reproducible measure of the global TCR Vβ repertoire diversity among twenty Vβ families in human peripheral blood. We also show that use of lower cell number results not in a dwindling of observed diversity but rather in non-reproducible patterns in replicate spectratypes. Finally, we report here a simple to use but sensitive method to quantify repertoire divergence in patient samples by comparison to a standard repertoire profile we generated from fifteen normal donors. We provide examples using this method to statistically evaluate the changes in the global TCR Vβ repertoire diversity that may take place during T subset immune reconstitution after hematopoietic stem cell transplantation or after immune modulating therapies.

摘要

T 细胞受体多样性分析提供了一种与临床相关且敏感的受体库缺失、获得或偏向标志物。谱型分析是一种广泛应用的技术,通过分析每个 Vβ 家族的 CDR3 片段的长度来测量全局 TCR 多样性。然而,当临床环境中可用的 T 细胞数量有限时,例如在移植方案之后,使用大量的 T 细胞来获得 TCR Vβ CDR3 多样性的全局视图会限制谱型分析。在这里,我们证明了一万个 T 细胞足以获得人类外周血中二十个 Vβ 家族之间全局 TCR Vβ 受体库多样性的稳健、高度可重复的测量。我们还表明,使用较少的细胞数量不会导致观察到的多样性减少,而是导致重复谱型中不可重复的模式。最后,我们在这里报告了一种简单易用但敏感的方法,通过与我们从十五个正常供体中生成的标准受体谱进行比较,来定量患者样本中受体库的发散。我们提供了使用该方法的示例,以统计评估造血干细胞移植或免疫调节治疗后 T 细胞亚群免疫重建过程中可能发生的全局 TCR Vβ 受体库多样性的变化。

相似文献

引用本文的文献

3
Recent Advancements in Regenerative Approaches for Thymus Rejuvenation.再生方法在胸腺年轻化中的最新进展。
Adv Sci (Weinh). 2021 May 7;8(14):2100543. doi: 10.1002/advs.202100543. eCollection 2021 Jul.
6
The era of immunogenomics/immunopharmacogenomics.免疫基因组学/免疫药物基因组学时代。
J Hum Genet. 2018 Jul;63(8):865-875. doi: 10.1038/s10038-018-0468-1. Epub 2018 May 21.

本文引用的文献

7
Thymus transplantation in complete DiGeorge anomaly.完全性DiGeorge异常中的胸腺移植
Immunol Res. 2009;44(1-3):61-70. doi: 10.1007/s12026-008-8082-5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验